B Braun's profits fall 12% in 1996
This article was originally published in Clinica
Executive Summary
German healthcare company B Braun Melsungen saw total sales rise 6% to DM 3,172 million ($2,115 million) in 1996. Net profits, however, fell 12% compared with an increase of 18% last year. The company attributes the fall in profitability to price pressures in its main market, Europe, which accounts for over 70% of total sales. Sales increases were recorded in South America and Asia, while the US, France and Germany experienced the highest sales losses, mainly through falling prices.
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.